Overview

An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether early use of a bland emollient in newborns, prior to the clinical signs of skin disease, will delay the onset or prevent the development of atopic dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborators:
Galderma
Galderma R&D
National Eczema Association
Treatments:
Emollients